Skip to main content
. 2022 Nov 9;3:1031368. doi: 10.3389/fpain.2022.1031368

Figure 2.

Figure 2

CONSORT diagram. Of the 31 patients assessed for eligibility, 8 patients were excluded or declined to participate. The remaining 23 patients were randomized to exclusively receive either active transcutaneous cervical vagus nerve stimulation (tcVNS) or sham stimulation. Two participants’ data in the active group were unusable due to equipment malfunctions. An additional participant from the active group withdrew from the study. The analysis thus included data from 9 patients in the active group and 11 patients in the sham group.